BLFS

BioLife Solutions, Inc. (NASDAQ:BLFS) is a specialized biotechnology company founded in 1987 and headquartered in Bothell, Washington. The company went public in 1989 and has evolved into a leading provider of bioproduction tools and services specifically designed for the cell and gene therapy industry. Over its decades-long history, BioLife has strategically focused on developing and manufacturing critical preservation and processing solutions that enable the safe storage, transport, and manufacturing of biological therapies. The company has recently undergone significant portfolio reshaping, divesting non-core businesses to concentrate on its higher-margin cell processing platform, positioning itself as a key enabler in the rapidly growing cell and gene therapy market.